Open AccessPerioperative Therapy in Renal Cell Carcinoma: What Do We Know, What Have We Learned, What's Next?
Author(s) -
Naomi B. Haas,
Robert G. Uzzo
Publication year - 2018
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.2018.78.9131
Subject(s) - pazopanib , medicine , sunitinib , axitinib , sorafenib , renal cell carcinoma , perioperative , adjuvant , oncology , adjuvant therapy , tyrosine kinase inhibitor , kidney cancer , clinical trial , placebo , cancer , surgery , pathology , hepatocellular carcinoma , alternative medicine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom